Combination therapy approved for the treatment of HCV/HIV co-infection in Europe

Posted: 4-Feb-2005 << BACK

The European Commission has approved Pegasus (peginterferon alfa-2a (40KD)) in combination with ribavirin for the treatment of chronic hepatitis C (HCV) in clinically stable patients co-infected with HIV. For the full article click here